Individualized mRNA cancer vaccines make strides

IO_AdminUncategorized3 days ago6 Views

The first cancer vaccines matched to a person’s unique tumor neoantigens are forging ahead, with expectations running high as the field awaits results from the first pivotal trial.

Access options

Access Nature and 54 other Nature Portfolio journals

Get Nature+, our best-value online-access subscription

27,99 € / 30 days

cancel any time

Subscribe to this journal

Receive 12 print issues and online access

195,33 € per year

only 16,28 € per issue

Buy this article

  • Purchase on SpringerLink
  • Instant access to full article PDF

Prices may be subject to local taxes which are calculated during checkout

Author information

Authors and Affiliations

  1. Dublin, Ireland

    Cormac Sheridan

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sheridan, C. Individualized mRNA cancer vaccines make strides.
Nat Biotechnol (2025). https://doi.org/10.1038/s41587-025-02708-7

Download citation

  • Published:

  • DOI: https://doi.org/10.1038/s41587-025-02708-7

Read More

0 Votes: 0 Upvotes, 0 Downvotes (0 Points)

Leave a reply

Recent Comments

No comments to show.

Stay Informed With the Latest & Most Important News

I consent to receive newsletter via email. For further information, please review our Privacy Policy

Advertisement

Loading Next Post...
Follow
Sign In/Sign Up Sidebar Search Trending 0 Cart
Popular Now
Loading

Signing-in 3 seconds...

Signing-up 3 seconds...

Cart
Cart updating

ShopYour cart is currently is empty. You could visit our shop and start shopping.